AI-generated synthesis of your health data across six core physiological systems.
Alex's metabolic markers show a consistent improvement arc. In 2021, HbA1c, fasting glucose, and LDL were all borderline high. By January 2024, all metabolic markers reached optimal levels simultaneously. This 'Metabolic Milestone' indicates significantly improved insulin sensitivity and cardiovascular risk profile.
Overall systemic inflammation is well controlled. A notable spike in hs-CRP (4.1 mg/L) occurred in January 2022 alongside elevated ALT, suggesting acute physiological stress or minor illness. This resolved completely by the next report, showing good immune resilience.
Vitamin D levels experienced a significant deficit cycle between March 2021 and June 2022. It appears a supplementation protocol corrected this by January 2023, and levels have remained optimally sustained since. Vitamin B12 shows a slow multi-year declining trend that warrants monitoring.
Hepatic and renal function markers are robust. An isolated elevation in ALT during January 2022 correlated with the inflammation spike but has remained firmly within the optimal range since.
Testosterone remains consistently in the upper quartile for Alex's age group, indicating excellent endocrine health and likely supported by good lifestyle factors.
Thyroid stimulating hormone (TSH) has been remarkably stable over the 5-year period, showing no evidence of hypo- or hyper-thyroid drift.
These insights are generated by analyzing the relationships between different biomarkers over time. They are not medical advice.